FGFR inhibitor PD173074, Purity ≥98%

Cat. No.: X24-06-ZQ103

FGFR inhibitor PD173074, Purity ≥98%

Synonym: 219580-11-7; FGFR inhibitor; PD-173074

  • MDL: MFCD08705327
  • CAS Number: 219580-11-7
  • Compound CID: 1401
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PD173074, soluble in DMSO and ethanol and insoluble in water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets c-Src, VEGFR2, EGFR, FGFR1, Insulin receptor, MEK, and PKC.
Molecular Weight
523.7
Molecular Formula
C28H41N7O3
Targets
c-Src: 19.8 μM; VEGFR2: 100-200 nM; EGFR: >50 μM; FGFR1: 25 nM; Insulin receptor: >50 μM; MEK: >50 μM; PKC: >50 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 86 mg/mL (164.22 mM); Water: Insoluble; Ethanol: 86 mg/mL (164.22 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD173074 aids in the study of FGFR inhibition in cancer research, targeting FGFR’s role in tumor progression.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0